Company intelligence / Profile preview

ABF Décisions

Ownership: Private
Development stage: Other

Overview

ABF Décisions is an independent French consulting firm specializing in market access strategies for pharmaceutical products and medical devices. The company offers expertise across pricing & reimbursement strategy design and implementation within the French healthcare system as well as broader European contexts. Their services include health economic modeling/analysis to support value demonstration to payers/regulators. They do not develop drugs, conduct clinical trials themselves or own proprietary therapeutic platforms—rather they act as strategic advisors to life science companies seeking successful product launches and optimal reimbursement outcomes within complex regulatory environments.

Industry: Consulting

Beyond the preview

Go deeper on ABF Décisions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABF Décisions.

Explore the full profile